A Prospective Phase 2 Trial of Reirradiation With Stereotactic Body Radiation Therapy Plus Cetuximab in Patients With Previously Irradiated Recurrent Squamous Cell Carcinoma of the Head and Neck

SBRT with concurrent cetuximab appears to be a safe salvage treatment for rSCCHN of short overall treatment time.